MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmjonc-2024-000472

Медицинская библиотека · BMJ oncology · 2024

Enhanced immune responses are accompanied by increased MAGEA expression in osteosarcoma metastases.

Meijer Debora M, van Oost Siddh, Roelands Jessica P, Ruano Dina, Briaire-de Bruijn I H, van den Akker B E, Kruisselbrink A B, Wijers-Koster P M, van der Ploeg Manon, Ijsselsteijn Marieke, Lam S W, de Ru Arnoud H, Tjokrodirijo R T N, van de Sande M A J, Gelderblom Hans, Van Veelen Peter A, Kuijjer M L, de Miranda Noel, Bovee Judith V M G

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Osteosarcoma is the most common primary bone sarcoma. About 50% of patients develop metastatic disease and their 5-year survival lingers at around 20%-30%. T cell checkpoint blockade immunotherapies have revolutionised cancer treatment in the last decade, but their impact remains limited in osteosarcoma.

METHODS AND ANALYSIS: In order to reveal potentially novel immunotherapeutic strategies for advanced osteosarcoma, we conducted an immunogenomic characterisation of a unique sample set comprising 30 osteosarcoma samples from seven patients, collected throughout disease progression. We performed RNA-sequencing and imaging mass cytometry analysis on these samples to reveal the immunological landscape during osteosarcoma progression.

RESULTS

Transcriptional and phenotypical hallmarks of cytotoxic T cell-driven anticancer immunity were enriched in metastatic lesions as compared with primary tumours. Spatial analysis showed T cells infiltrating central regions of osteosarcoma metastases, indicating the absence of an immune excluded environment. In parallel, we found a pronounced increase in the expression of cancer testis antigens, particularly melanoma antigen family A (MAGEA)-related antigens, in osteosarcoma metastases, which was validated in an independent cohort (N=91). In addition, we demonstrated the presentation of MAGE-derived peptides in three out of four osteosarcoma cell lines.

CONCLUSION

These findings indicate a concurrent augmentation of cytotoxic antitumour immune responses and expression of MAGEA antigens from primary to metastatic osteosarcoma. This observation suggests the exploration of MAGEA antigens as potential targets for immunotherapy in the treatment of advanced osteosarcoma.

Для цитирования: Meijer Debora M, van Oost Siddh, Roelands Jessica P, Ruano Dina, Briaire-de Bruijn I H, van den Akker B E, Kruisselbrink A B, Wijers-Koster P M, van der Ploeg Manon, Ijsselsteijn Marieke, Lam S W, de Ru Arnoud H, Tjokrodirijo R T N, van de Sande M A J, Gelderblom Hans, Van Veelen Peter A, Kuijjer M L, de Miranda Noel, Bovee Judith V M G. Enhanced immune responses are accompanied by increased MAGEA expression in osteosarcoma metastases.. BMJ oncology. 2024. DOI: 10.1136/bmjonc-2024-000472.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.